1. Home
  2. ABP vs OXBR Comparison

ABP vs OXBR Comparison

Compare ABP & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • OXBR
  • Stock Information
  • Founded
  • ABP 2004
  • OXBR 2013
  • Country
  • ABP United States
  • OXBR Cayman Islands
  • Employees
  • ABP N/A
  • OXBR N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • OXBR Property-Casualty Insurers
  • Sector
  • ABP Health Care
  • OXBR Finance
  • Exchange
  • ABP Nasdaq
  • OXBR Nasdaq
  • Market Cap
  • ABP 17.2M
  • OXBR 15.1M
  • IPO Year
  • ABP N/A
  • OXBR 2014
  • Fundamental
  • Price
  • ABP $0.19
  • OXBR N/A
  • Analyst Decision
  • ABP Strong Buy
  • OXBR Strong Buy
  • Analyst Count
  • ABP 1
  • OXBR 1
  • Target Price
  • ABP $4.00
  • OXBR $5.00
  • AVG Volume (30 Days)
  • ABP 5.0M
  • OXBR 76.1K
  • Earning Date
  • ABP 11-18-2025
  • OXBR 11-12-2025
  • Dividend Yield
  • ABP N/A
  • OXBR N/A
  • EPS Growth
  • ABP N/A
  • OXBR N/A
  • EPS
  • ABP N/A
  • OXBR N/A
  • Revenue
  • ABP $183,000.00
  • OXBR $1,983,000.00
  • Revenue This Year
  • ABP N/A
  • OXBR $497.99
  • Revenue Next Year
  • ABP N/A
  • OXBR $42.14
  • P/E Ratio
  • ABP N/A
  • OXBR N/A
  • Revenue Growth
  • ABP 154.17
  • OXBR N/A
  • 52 Week Low
  • ABP $0.15
  • OXBR $1.27
  • 52 Week High
  • ABP $11.19
  • OXBR $5.81
  • Technical
  • Relative Strength Index (RSI)
  • ABP 43.91
  • OXBR 50.07
  • Support Level
  • ABP $0.19
  • OXBR $1.75
  • Resistance Level
  • ABP $0.21
  • OXBR $2.09
  • Average True Range (ATR)
  • ABP 0.02
  • OXBR 0.18
  • MACD
  • ABP -0.00
  • OXBR -0.03
  • Stochastic Oscillator
  • ABP 14.12
  • OXBR 28.85

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

Share on Social Networks: